期刊文献+

血管紧张素Ⅱ受体拮抗剂联合血管紧张素转换酶抑制剂对老年高血压病患者尿蛋白的影响 被引量:6

Antiproteinuric Effect of Combined ACE Inhibitor and AngiotensinⅡReceptor Blocker in Elderly with Hypertension
暂未订购
导出
摘要 目的 :观察血管紧张素Ⅱ 1型受体拮抗剂 (ARB)与血管紧张素转换酶抑制剂 (ACEI)联合应用对老年高血压病患者尿蛋白排泄的影响。方法 :2 5例确诊为原发性高血压的老年患者 ,测定基础血压水平、肾功能和 2 4小时尿蛋白定量 ,经贝那普利 (ACEI)治疗 4周后再次测定 2 4小时尿蛋白定量 ,然后加用伊贝沙坦 (ARB)治疗 4周 ,观察肾功能及 2 4小时尿蛋白定量的变化。结果 :2 5例老年原发性高血压患者平均 2 4小时尿蛋白定量0 8± 0 6g/d。贝那普利 10mg/d治疗后平均 2 4小时尿蛋白定量 0 5± 0 5g/d (与治疗前比较P <0 0 1) ;联合应用伊贝沙坦 15 0mg/d治疗 4周后 2 4小时尿蛋白定量 0 3± 0 4g/d ,与联用前比较差异显著 (P <0 0 1)。结论 :ACEI与ARB联合应用对老年原发性高血压减少尿蛋白排泄的作用优于ACEI单独应用。 Objective:Toinvestigatewhetheracombinationofanangiotensinconvertingenzymeinhibitor (ACEI,be nazepril)withanangiotensinreceptorblocker (ARB ,irbesartan)inelderlyhypertensivepatientsproducesamoreprofoundan tiproteinuriceffectthanACEIalone.Methods:Twenty -fivehypertensivepatientsaged 6 5orolderwerestudied .Bloodpressure measurementsandlaboratorytestsfor2 4hoursurinaryproteinandrenalfunctionwereperformedasfollows:(1)withoutmedica tionornon -ACEI (baseline) ;(2 )ACEIalone ;and (3)combinationofACEIandARB .Eachperiodlastedfor 4weeks. Results:ACEIalonereducedurinaryproteinfrom 0 8± 0 6g/dto 0 5± 0 5g/d (P <0 0 1)。ThecombinationofACEIand ARBinducedamoreremarkablereductionofurinaryproteinthanACEIalone (to 0 3± 0 4g/d ,P <0 0 1) .Conclusions:A combinationofACEIandARBinelderlyhypertensivepatientsproduceamoreprofounddecreaseinproteinuriathanACEIalone.
出处 《华西医学》 CAS 2003年第1期43-45,共3页 West China Medical Journal
关键词 血管紧张素Ⅱ受体拮抗剂 老年 高血压病 尿蛋白 ACEI ARB ACEI hypertension proteinuria elderly
  • 相关文献

参考文献8

  • 1[1]Agrawal B,Berger A,Wolf K,et al.Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension[J].J Hpertens,1996,14∶223-228.
  • 2[2]Deckert T,Feldt-Rasmaussen B,Borch-Johnsoen K,et al.Albuminuria reflects widespread vascular damage:the Steno hyposis[J].Diabetologia,1989,32∶219-226.
  • 3[3]Cinotti GA,Zucchelli PC.Collaborative Study Group.Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies[J].Nephrol Dial Transplant,2001,16∶961-966.
  • 4[4]Gasparo MDE,Levens NR.Pharmacology of angiotensin Ⅱ receptor in the kidney[J].Kidney Int,1994,46∶1486.
  • 5[5]Remuzzi A,Perticucci E,Reggenenti P,et al.Angiotensin converting enzyme inhibition improve glomarular size-selectivity in IgA nephropathy[J].Kidney Int,1991,39∶1267.
  • 6[6]Woo KT,Lau YK,Wong KS,et al.ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis[J].Kidney Int,2000,58∶2485-2491.
  • 7[7]Ferrari P,Marti HP,Pfister M,et al.Additive antiproteinuric effect of combined ACE inhibition and angiotensin Ⅱ receptor blockade[J].J Hypertens,2002,20∶125-130.
  • 8[8]Kincaid-Smith P,Fairley K,Packham D.Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin Ⅱ receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria[J].Nephrol Dial Transplant,2002,17∶597-601.

同被引文献32

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部